Facebook Linkedin RSS Twitter Youtube
Home 2024

Biopharmaceuticals

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational
Bioprocessing

Rentschler Biopharma’s New Production Line in Massachusetts Now Fully Operational

Nirrin Launches Atlas for At-Line Analysis at the Point of Sampling
Bioprocessing

Nirrin Launches Atlas for At-Line Analysis at the Point of Sampling

Personalized Meds Sector Should Look to Microfluidics for Purification
Bioprocessing

Personalized Meds Sector Should Look to Microfluidics for Purification

Supplementation Ups Titer and Growth of Yeast Spent Media
Bioprocessing

Supplementation Ups Titer and Growth of Yeast Spent Media

NIIMBL and OAGi Team Up to Help Drug Industry Align on Data
Bioprocessing

NIIMBL and OAGi Team Up to Help Drug Industry Align on Data

DOD Selects Just – Evotec Biologics for Biomanufacturing Optimization
Bioprocessing

DOD Selects Just – Evotec Biologics for Biomanufacturing Optimization

Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology
Cancer

Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology

Rethinking Data in Drug Manufacturing
Bioprocessing

Rethinking Data in Drug Manufacturing

AGC Biologics and BioConnection Partner to Offer Biodrug Product Development and Manufacturing
Bioprocessing

AGC Biologics and BioConnection Partner to Offer Biodrug Product Development and Manufacturing

Leukemia Therapy Approach “Deletes” Affected Blood System While Transplanting Healthy Stem Cells
Cancer

Leukemia Therapy Approach “Deletes” Affected Blood System While Transplanting Healthy Stem Cells

123...199Page 1 of 199

Recently Featured

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.